News headlines about Plexus (NASDAQ:PLXS) have trended somewhat positive recently, Accern reports. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Plexus earned a news impact score of 0.08 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 47.2943471976742 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Plexus (NASDAQ PLXS) opened at $57.64 on Wednesday. The company has a quick ratio of 1.08, a current ratio of 1.90 and a debt-to-equity ratio of 0.03. Plexus has a 1-year low of $49.06 and a 1-year high of $66.78. The company has a market capitalization of $1,936.13, a price-to-earnings ratio of -113.02 and a beta of 0.87.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, January 17th. The technology company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.05). Plexus had a negative net margin of 0.57% and a positive return on equity of 11.24%. The firm had revenue of $677.00 million during the quarter, compared to analyst estimates of $685.07 million. During the same period in the prior year, the company earned $0.82 earnings per share. The business’s quarterly revenue was up 6.6% compared to the same quarter last year. equities research analysts predict that Plexus will post 3.25 earnings per share for the current year.

PLXS has been the topic of a number of recent analyst reports. Citigroup boosted their target price on Plexus from $59.00 to $65.00 and gave the stock a “neutral” rating in a report on Friday, October 27th. Zacks Investment Research lowered Plexus from a “hold” rating to a “sell” rating in a report on Monday, October 30th. BidaskClub lowered Plexus from a “hold” rating to a “sell” rating in a report on Saturday, December 16th. ValuEngine raised Plexus from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Finally, Longbow Research raised Plexus from a “neutral” rating to a “buy” rating in a report on Monday, January 8th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. Plexus currently has an average rating of “Hold” and a consensus target price of $59.17.

In other news, Chairman Dean A. Foate sold 12,300 shares of the stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $63.41, for a total transaction of $779,943.00. Following the sale, the chairman now directly owns 295,220 shares of the company’s stock, valued at approximately $18,719,900.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman Dean A. Foate sold 16,925 shares of the stock in a transaction on Friday, November 17th. The stock was sold at an average price of $61.22, for a total value of $1,036,148.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 91,711 shares of company stock worth $5,713,908. Insiders own 3.70% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Plexus (PLXS) Earning Somewhat Favorable Press Coverage, Study Shows” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at

Plexus Company Profile

Plexus Corp. (Plexus) and its subsidiaries are engaged in the electronic manufacturing services (EMS) industry. The Company delivers end-to-end solutions for customers in the Americas (AMER), Europe, Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. The Company’s segments are AMER, APAC and EMEA.

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with's FREE daily email newsletter.